Is resistant starch protective against colorectal cancer via modulation of the WNT signalling pathway?

Proceedings of the Nutrition Society

Volumn 74, Issue 3, 2015, Pages 282-291

  Malcomson, Fiona C ^a   Willis, Naomi D ^a   Mathers, John C ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Butyrate; Colorectal cancer; Non digestible carbohydrates; Resistant starch; WNT signalling

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE INHIBITOR; MICRORNA; RESISTANT STARCH; STARCH; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BUTYRIC ACID DERIVATIVE; CELL SURFACE RECEPTOR; G-PROTEIN COUPLED RECEPTOR 43, HUMAN; VOLATILE FATTY ACID;

APOPTOSIS; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONFERENCE PAPER; CRYPT CELL; DIETARY FIBER; DNA METHYLATION; GENE EXPRESSION; HUMAN; LARGE INTESTINE; NONHUMAN; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; BIOSYNTHESIS; COLON; COLORECTAL NEOPLASMS; DRUG EFFECTS; GENETIC EPIGENESIS; METABOLISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BUTYRATES; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; EPIGENESIS, GENETIC; FATTY ACIDS, VOLATILE; HUMANS; RECEPTORS, CELL SURFACE; STARCH; WNT SIGNALING PATHWAY;

EID: 84937642699     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S002966511500004X     Document Type: Conference Paper

References (96)

1. Cancer Research UK. Bowel cancer key facts. (2014) http://www.cancerresearchuk.org/cancer-info/cancerstats/keyfacts/bowel-cancer/ (accessed August 2014).
2. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
3. Parkin DM, Boyd L, Walker LC (2011) 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 105 Suppl 2, S77-S81.
4. World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous update project report. Food, nutrition, physical activity, and the prevention of colorectal cancer.
5. th session of the Codex Commitee on nutrition and foods for special dietary uses. http://www.codexalimentarius.net/download/report/710/al32-26e.pdf (accessed August 2014).
6. Cummings JH & Stephen AM (2007) Carbohydrate terminology and classification. Eur J Clin Nutr 61 Suppl 1, S5-18.
7. Topping DL & Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064.
8. Burkitt DP (1971) Epidemiology of cancer of the colon and rectum. Cancer 28, 3-13.
9. Aune D, Chan DS, Lau R et al. (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. Br Med J 343, d6617.
10. Hylla S, Gostner A, Dusel G et al. (1998) Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. Am J Clin Nutr 67, 136-142.
11. Lipkin M, Reddy B, Newmark H et al. (1999) Dietary factors in human colorectal cancer. Annu Rev Nutr 19, 545-586.
12. Williams EA, Coxhead JM & Mathers JC (2003) Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc Nutr Soc 62, 107-115.
13. Pryde SE, Duncan SH, Hold GL et al. (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217, 133-139.
14. Hamer HM, Jonkers D, Venema K et al. (2008) Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104-119.
15. Bordonaro M, Lazarova DL & Sartorelli AC (2008) Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle 7, 1178-1183.
16. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480.
17. Bienz M & Clevers H (2000) Linking colorectal cancer to Wnt signaling. Cell 103, 311-320.
18. Schneikert J & Behrens J (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56, 417-425.
19. Sierra J, Yoshida T, Joazeiro CA et al. (2006) The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev 20, 586-600.
20. Luo J, Chen J, Deng ZL et al. (2007) Wnt signaling and human diseases: what are the therapeutic implications? Lab Invest 87, 97-103.
21. Klaus A & Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8, 387-398.
22. Kinzler KW & Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87, 159-170.
23. Morin PJ, Sparks AB, Korinek V et al. (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275, 1787-1790.
24. Caldwell GM, Jones C, Gensberg K et al. (2004) The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64, 883-888.
25. Bauer-Marinovic M, Florian S, Muller-Schmehl K et al. (2006) Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon. Carcinogenesis 27, 1849-1859.
26. Le Leu RK, Brown IL, Hu Y et al. (2007) Suppression of azoxymethane-induced colon cancer development in rats by dietary resistant starch. Cancer Biol Ther 6, 1621-1626.
27. Alrawi SJ, Schiff M, Carroll RE et al. (2006) Aberrant crypt foci. Anticancer Res 26, 107-119.
28. Liu R & Xu G (2008) Effects of resistant starch on colonic preneoplastic aberrant crypt foci in rats. Food Chem Toxicol 46, 2672-2679.
29. Thorup I, Meyer O & Kristiansen E (1995) Effect of potato starch, cornstarch and sucrose on aberrant crypt foci in rats exposed to azoxymethane. Anticancer Res 15, 2101-2105.
30. Cassand P, Maziere S, Champ M et al. (1997) Effects of resistant starch- and vitamin A-supplemented diets on the promotion of precursor lesions of colon cancer in rats. Nutr Cancer 27, 53-59.
31. Sakamoto J, Nakaji S, Sugawara K et al. (1996) Comparison of resistant starch with cellulose diet on 1,2-dimethylhydrazine-induced colonic carcinogenesis in rats. Gastroenterology 110, 116-120.
32. Maziere S, Meflah K, Tavan E et al. (1998) Effect of resistant starch and/or fat-soluble vitamins A and E on the initiation stage of aberrant crypts in rat colon. Nutr Cancer 31, 168-177.
33. Young GP, McIntyre A, Albert V et al. (1996) Wheat bran suppresses potato starch-potentiated colorectal tumorigenesis at the aberrant crypt stage in a rat model. Gastroenterology 110, 508-514.
34. Smits R, Kartheuser A, Jagmohan-Changur S et al. (1997) Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 18, 321-327.
35. Williamson SL, Kartheuser A, Coaker J et al. (1999) Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months. Carcinogenesis 20, 805-810.
36. Cray NL (2013) Effects of diets containing digestion-resistant starch on Wnt pathway control of proliferation and differentiation of the colorectal mucosa. Ames, Iowa: Iowa State University.
37. Bordonaro M, Mariadason JM, Aslam F et al. (1999) Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ 10, 713-720.
38. Bordonaro M, Lazarova DL & Sartorelli AC (2007) The activation of beta-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res 313, 1652-1666.
39. Vincan E, Leet CS, Reyes NI et al. (2000) Sodium butyrate-induced differentiation of human LIM2537 colon cancer cells decreases GSK-3beta activity and increases levels of both membrane-bound and Apc/axin/GSK-3beta complex-associated pools of beta-catenin. Oncol Res 12, 193-201.
40. Wong NA & Pignatelli M (2002) Beta-catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160, 389-401.
41. Zhang W, Hart J, McLeod HL et al. (2005) Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms. Am J Clin Pathol 124, 11-19.
42. Germann A, Dihlmann S, Hergenhahn M et al. (2003) Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin. Int J Cancer 106, 187-197.
43. Wilson AJ, Velcich A, Arango D et al. (2002) Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Res 62, 6006-6010.
44. Lazarova D, Lee A, Wong T et al. (2014) Modulation of Wnt activity and cell physiology by butyrate in LT97 microadenoma cells. J Cancer 5, 203-213.
45. Lazarova DL, Chiaro C & Bordonaro M (2014) Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells. BMC Res Notes 7, 226.
46. Mathers JC, Strathdee G & Relton CL (2010) Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet 71, 3-39.
47. Dupont C, Armant DR & Brenner CA (2009) Epigenetics: definition, mechanisms and clinical perspective. Semin Reprod Med 27, 351-357.
48. Struhl K (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12, 599-606.
49. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8, 286-298.
50. Berni Canani R, Di Costanzo M & Leone L (2012) The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 4, 4.
51. Fung KY, Cosgrove L, Lockett T et al. (2012) A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 108, 820-831.
52. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16, 6-21.
53. Robertson KD (2001) DNA methylation, methyltransferases, and cancer. Oncogene 20, 3139-3155.
54. Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6, 597-610.
55. Baylin SB & Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16, 168-174.
56. Worthley DL, Le Leu RK, Whitehall VL et al. (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90, 578-586.
57. Shin H, Kim JH, Lee YS et al. (2012) Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Int J Oncol 40, 1533-1542.
58. Bentwich I, Avniel A, Karov Y et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37, 766-770.
59. Lewis BP, Burge CB & Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
60. Calin GA & Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866.
61. Humphreys KJ, Conlon MA, Young GP et al. (2014) Dietary manipulation of oncogenic microRNA expression in human rectal Mucosa: a randomized trial. Cancer Prev Res (Phila) 7, 786-795.
62. Humphreys KJ, Cobiac L, Le Leu RK et al. (2013) Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol Carcinog 52, 459-474.
63. Dronamraju SS, Coxhead JM, Kelly SB et al. (2010) Differential antineoplastic effects of butyrate in cells with and without a functioning DNA mismatch repair. Nutr Cancer 62, 105-115.
64. Wacker M, Wanek P, Eder E et al. (2002) Effect of enzyme-resistant starch on formation of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal and cell proliferation in the colonic mucosa of healthy volunteers. Cancer Epidemiol Biomarkers Prev 11, 915-920.
65. Dronamraju SS, Coxhead JM, Kelly SB et al. (2009) Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial. Gut 58, 413-420.
66. Mills SJ, Shepherd NA, Hall PA et al. (1995) Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut 36, 391-394.
67. Terpstra OT, van Blankenstein M, Dees J et al. (1987) Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 92, 704-708.
68. Scheppach W, Bartram P, Richter A et al. (1992) Effect of short-chain fatty acids on the human colonic mucosa in vitro. JPEN J Parenter Enteral Nutr 16, 43-48.
69. Kien CL, Blauwiekel R, Bunn JY et al. (2007) Cecal infusion of butyrate increases intestinal cell proliferation in piglets. J Nutr 137, 916-922.
70. Mortensen FV, Langkilde NC, Joergensen JC et al. (1999) Short-chain fatty acids stimulate mucosal cell proliferation in the closed human rectum after Hartmann's procedure. Int J Colorectal Dis 14, 150-154.
71. Key FB, McClean D & Mathers JC (1996) Tissue hypertrophy and epithelial proliferation rate in the gut of rats fed on bread and haricot beans (Phaseolus vulgaris). Br J Nutr 76, 273-286.
72. Comalada M, Bailon E, de Haro O et al. (2006) The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol 132, 487-497.
73. Hodin RA, Meng S, Archer S et al. (1996) Cellular growth state differentially regulates enterocyte gene expression in butyrate-treated HT-29 cells. Cell Growth Differ 7, 647-653.
74. Romagnolo B, Berrebi D, Saadi-Keddoucci S et al. (1999) Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res 59, 3875-3879.
75. Wong MH, Huelsken J, Birchmeier W et al. (2002) Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling. J Biol Chem 277, 15843-15850.
76. Lazarova DL, Bordonaro M, Carbone R et al. (2004) Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer 110, 523-531.
77. Groden J, Joslyn G, Samowitz W et al. (1995) Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene. Cancer Res 55, 1531-1539.
78. Morin PJ, Vogelstein B & Kinzler KW (1996) Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A 93, 7950-7954.
79. Zhang T, Otevrel T, Gao Z et al. (2001) Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61, 8664-8667.
80. Nofrarias M, Martinez-Puig D, Pujols J et al. (2007) Long-term intake of resistant starch improves colonic mucosal integrity and reduces gut apoptosis and blood immune cells. Nutrition 23, 861-870.
81. Claus R, Losel D, Lacorn M et al. (2003) Effects of butyrate on apoptosis in the pig colon and its consequences for skatole formation and tissue accumulation. J Anim Sci 81, 239-248.
82. Armstrong F & Mathers JC (2000) Kill and cure: dietary augmentation of immune defences against colon cancer. Proc Nutr Soc 59, 215-220.
83. Avivi-Green C, Polak-Charcon S, Madar Z et al. (2002) Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines. J Nutr 132, 1812-1818.
84. Purwani E, Iskandriati D & Suhartono M (2012) Fermentation product of RS3 inhibited proliferation and induced apoptosis in colon cancer cell HCT-116. Adv. Biosci. Biotechnol. 3, 1189-1198.
85. Clarke JM, Young GP, Topping DL et al. (2012) Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats. Carcinogenesis 33, 197-202.
86. Winter J, Young GP, Hu Y et al. (2014) Accumulation of promutagenic DNA adducts in the mouse distal colon after consumption of heme does not induce colonic neoplasms in the western diet model of spontaneous colorectal cancer. Mol Nutr Food Res 58, 550-558.
87. Le Leu RK, Hu Y, Brown IL et al. (2010) Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 31, 246-251.
88. Bordonaro M, Tewari S, Atamna W et al. (2011) The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways. Exp Cell Res 317, 1368-1381.
89. Zuo L, Lu M, Zhou Q et al. (2013) Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food Chem Toxicol 62, 892-900.
90. Mathers JC, Movahedi M, Macrae F et al. (2012) Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol 13, 1242-1249.
91. van Munster IP, Tangerman A & Nagengast FM (1994) Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci 39, 834-842.
92. Burn J, Bishop DT, Chapman PD et al. (2011) A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) 4, 655-665.
93. van Gorkom BA, Karrenbeld A, van der Sluis T et al. (2002) Calcium or resistant starch does not affect colonic epithelial cell proliferation throughout the colon in adenoma patients: a randomized controlled trial. Nutr Cancer 43, 31-38.
94. Grubben MJ, van den Braak CC, Essenberg M et al. (2001) Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Dig Dis Sci 46, 750-756.
95. Jacobasch G, Schmiedl D, Kruschewski M et al. (1999) Dietary resistant starch and chronic inflammatory bowel diseases. Int J Colorectal Dis 14, 201-211.
96. Mentschel J & Claus R (2003) Increased butyrate formation in the pig colon by feeding raw potato starch leads to a reduction of colonocyte apoptosis and a shift to the stem cell compartment. Metabolism 52, 1400-1405.